Meat May Lower Dementia Risk in APOE4 Carriers
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Karolinska Institutet researchers found that older adults carrying APOE 3/4 and 4/4 gene variants who ate the most meat showed slower cognitive decline and lower dementia risk, in a 15-year study of 2,100+ adults published in JAMA Network Open.
- APOE 3/4 and 4/4 carriers who ate less meat had more than twice the dementia risk of people without these variants, but this elevated risk was absent in the highest-intake group, whose median consumption was about 870 grams of meat per week (adjusted to 2,000 daily calories).
- A lower proportion of processed meat within total meat intake was linked to reduced dementia risk regardless of APOE genotype, according to co-author Sara Garcia-Ptacek.
- APOE 3/4 and 4/4 carriers who ate more unprocessed meat also had significantly lower all-cause mortality in a follow-up analysis.
- First author Jakob Norgren called for clinical trials to develop genotype-tailored dietary recommendations, stressing that the observational design cannot prove causation.
- Roughly 30% of people in Sweden carry APOE 3/4 or 4/4 variants, and nearly 70% of Swedish Alzheimer's patients have one of these combinations — making Nordic populations especially well suited to this research, per the authors.
Why it matters: For the roughly 30% of Northern Europeans carrying high-risk APOE variants, conventional advice to cut red meat may be working against their brain health — but only randomized clinical trials can confirm whether dietary change actually modifies the genetically elevated dementia risk observed in this 15-year observational study.
